Related by context. All words. (Click for frequent words.) 55 Normalised earnings 54 SEK -#.# -#.# [002] 54 Normalised 54 Hb A1C 53 Pro forma EPS 53 Non GAAP Operating Margin 53 profit beia 53 totaled EUR#.#m 53 beia 53 Fully diluted EPS 53 #.#mln [007] 53 Headline PBIT 52 Non IFRS 52 IFRS IFRS 52 excluding reimbursables 52 Annualized ROE 52 apolipoprotein B 52 mmol l 52 odds ratios ORs 52 operatingincome 51 Adjusted Ebitda 51 HbA1C levels 51 albumin excretion 51 EBITD 51 EURm 51 - - [046] 51 French Gaap 51 swaps 2s #.#bps 51 EBIT amounted 51 EBIAT 51 comparedwith 51 SEK -#.# -#.# [003] 51 2bps wider 51 Lubrizol Additives segment 51 Pro forma EBITDA 50 homocysteine concentrations 50 Medicare Advantage MLR 50 hemoglobin A1c HbA1c 50 Fasting glucose 50 urine albumin 50 mm Hg diastolic 50 totaled EUR#.# 50 EBT amounted 50 EBIT beia 50 #.#bn rub [004] 50 Adjusted Gross Profit 50 #.#-#.# bln dkr [002] 50 - Non GAAP [031] 50 Adverse effects 50 Non GAAP Diluted EPS 50 excludes acquisitions divestitures 50 glycated hemoglobin 50 PDP MLR 50 nonroutine income 50 increaseof 50 Recommended Dietary Allowance 50 Fully taxable 50 ROAs 49 hemoglobin A1C 49 OCF margin 49 peak VO2 49 Adjusted EBITDA1 49 venous thromboembolism VTE prophylaxis 49 AST ALT 49 #.#bn rub [003] 49 #.#cps [002] 49 excludes unrealized gains 49 margin teb 49 #.#x #.#x [002] 49 museum Julie Setlock 49 REIT Taxable 49 #.#mmol l [002] 49 metabolite concentrations 49 MBS AFS increased 49 leukocyte count 49 allowance RDA 49 capital employed ROACE 49 Recommended Dietary Allowance RDA 49 NNT = 49 Adjusted EBITA 49 consolidated OIBDA margin 49 Embedded Value EEV 49 9M FY# [001] 49 midswaps plus 49 g h 49 % CI #.#-#.# [004] 49 AIFRS 49 % Confidence Interval 49 symptomatic intracranial hemorrhage 49 #.#bln rbl [003] 49 DAC unlock 49 EUR -#.# [001] 49 albumin excretion rate 49 Platelet counts 49 THB# #mn 49 EUR#.#b 49 Efficiency ratio FTE 49 #M/# 49 securitization exposures 49 MSEK -#.# 49 Depreciations 49 #.# bln dkr [001] 49 Realized Earnings 48 #.#-#.# [002] 48 intact parathyroid hormone 48 SEK -#.# [003] 48 items affecting comparability 48 CRD3 48 LFQ gross 48 triglyceride concentration 48 baseline serum bilirubin 48 Biochip Array Technology 48 Munghana Lonene Listenership 48 CI -#.# 48 PLN #.#mn [001] 48 adjusted OIBDA margin 48 #.#-#.# bln eur [003] 48 Underwriting Income Loss 48 Sees FY# revs 48 REBIT 48 DVFA SG 48 μmol L 48 CGAAP 48 9M FY# [002] 48 clopidogrel pretreatment 48 operating income1 48 Levels Linked 48 #.#mlrd rbl [002] 48 Blended ARPU 48 Pneumococcal vaccination 48 μg L 48 Constant Currency 48 SEK -#.# [001] 48 Generally Accepted Accounting Principle 48 PASI scores 48 weightages 48 pretest probability 48 Walgreen 2Q 48 #.#.# [011] 48 hemoglobin A1c levels 48 EUR -#.# -#.# [002] 48 revenues excluding nonrecurring 48 Capital Employed 48 achieving hemostasis 48 expenses totaled Ps 48 mIU ml 48 SEK#.#bn [004] 48 #.#-#.# [005] 48 Dhs1 #m 48 Adjust ments 48 mean ± SEM 48 USPSTF recommends 48 fludrocortisone 48 MEUR -#.# 47 was#.# 47 #.# bln skr [002] 47 MMSE scores 47 mL/min/#.# m 2 47 #.#p #.#p [004] 47 intersegment eliminations 47 echocardiographic parameters 47 EUR #,# Mio 47 transaminases 47 vitamin D metabolites 47 ALT elevation 47 Partially offset 47 calcium phosphorus 47 Underlying pretax 47 - Adjusted [005] 47 kcal d 47 excluding exceptionals 47 +3 bps 47 Calorie intake 47 Interest Expenses 47 Unfavourable Changes 47 IAROC 47 Exceptional Items 47 adjusted1 47 #.#p #.#p [007] 47 CAMELS rating 47 prioryear 47 ASC Topic #-# 47 margin FTE 47 DKK #m 47 IFRS changeover 47 - - Non GAAP [001] 47 carb dieters 47 #.#mln rub [002] 47 Leverage ratios 47 - -Belusko 47 non gaap 47 PBDIT 47 CFR § #.# [006] 47 acquisitions divestments 47 Recurring EBITDA 47 Q1 #F 47 serum urate 47 HbA 1C 47 excluding goodwill impairment 47 Realized Volatility 47 ROACE 47 adjusted2 47 Currency translation negatively impacted 47 amortization Ebita 47 Oxy ER 47 Annualised 47 noninterest expense divided 47 Triglyceride levels 47 TWACS NG software 47 Pharmacokinetic parameters 47 nonfasting triglyceride levels 47 confidence intervals CIs 47 Payout Ratio 47 CGBs 47 LTM EBITDA ratio 47 excluding BIBP 47 Embedded Value 47 M Models Excluded 47 MMSE score 47 efficiency ratio teb 47 WWS Divestiture 47 alanine aminotransferase 47 per MCFE 47 weighted avg 47 Cont Ops 47 #.#-#.# [011] 47 -1 -2 47 Comparative Figures 47 - Adjusted [010] 47 HK#.# cents [001] 47 CFR § #.# [004] 47 USGAAP 47 retrospectively adjusted 47 SFAS No.# 47 excl 47 serum PTH 47 Clinical Practice Guideline 47 ROAA 47 creatinine clearance CrCl 47 Matches Estimate 47 tertiles 46 - - [062] 46 Adjusted Margin 46 RfD 46 NPVs 46 #/#mmHg 46 c Relates 46 -By DON HUNTER 46 MNOK #,# 46 Trades -#.# 46 Fitch BBB medians 46 Amorti 46 HbA 1c levels 46 depreciation amortization accretion 46 MFFO 46 GBPm GBPm GBPm 46 ROATE 46 #.#mg l [001] 46 Tangible Equity 46 CDAI score 46 Standardized distributable cash 46 noninterest expense decreased 46 Expense ratios 46 logistic regression model 46 Gross Margin Gross 46 glycated hemoglobin HbA1c 46 mcg albinterferon alfa 2b 46 expense disallowances 46 Liquidity Ratio 46 GBPm 46 FRSSE 46 FFOPS 46 GAAP Diluted EPS 46 MINIMUM REQUIREMENTS 46 cross sectionally 46 average assets ROAA 46 below SBAR 46 Ps.3 46 FY# FY# FY# 46 weakly correlated 46 Adjusted EBIT 46 items impacting comparability 46 #,# #,# #,# #,# [002] 46 Counterparty Criteria 46 deciliter 46 NOI decreased 46 pre exceptionals 46 Rates Euribor 46 CICA Section 46 #IU [001] 46 Continuing Ops 46 Excludes amortization 46 Duration Gap 46 System IPSS 46 Loss Severity 46 EBITA amounted 46 - Adjusted [034] 46 EBITDAO 46 nonGAAP 46 adjusted1 net 46 fructosamine 46 - Adjusted [019] 46 ¥ #.#b 46 notes UST2YR declined 46 Realized Gains 46 anincrease 46 - -plumbers pipefitters 46 YTD Q3 46 IBIs 46 adjusted EBITDAR 46 intima media thickness 46 #.degree [001] 46 IRRs 46 FHLB advances decreased 46 FFO payout ratio 46 intangibles amortization 46 HOMA IR 46 mmHg diastolic 46 LDL triglycerides 46 EBITDAA 46 - - [019] 46 Gross Addition CPGA 46 calcium intakes 46 #.#mlrd rbl [001] 46 #mln rub [001] 46 Month Avg 46 Detrex Corporation Reports 46 La.Code Crim.P. art 46 CICA Handbook Sections 46 EBITDAF 46 NOL utilization 46 blood glucose concentrations 46 Unallocated expenses 46 Funded Debt 46 waist circumference measurements 46 Return IRR x Amortized 46 CICA Accounting Guideline 46 ADCS ADL 46 continuingoperations 46 -planting saplings 46 SEK1 #m 46 2bps tighter 46 Approaching Basic 45 -#.# log# 45 EEV basis 45 Before Unusual Items 45 Standardized Approach 45 TEB adjustment 45 hematological parameters 45 Nonoperating 45 lowest tertile 45 Baseline characteristics 45 amortisations 45 #-#/# #-#/# [006] 45 Reported ments 45 - Adjusted [028] 45 Ratios 45 Pro forma diluted 45 taxable equivalent FTE 45 #-#.# BID 45 Dividend Payout Ratio 45 #.#mmol L [002] 45 #compared 45 JPY#.# billion [001] 45 Standardized Distributable Cash 45 Adjusted EBT 45 - -Corporatism 45 FTE staffing 45 Coming Biotech Boom 45 diluted EPADS 45 Balance Sheet Cash Flow 45 Unlevered Cash Flow 45 undepreciated real estate 45 AHML 45 per ASM CASM 45 baseline HbA1c 45 invoiced shipments 45 CHF#.#B 45 Operating netback 45 - - Non arachnophobes 45 NJAC #:#-#.# 45 Average Assets ROAA 45 Hazard Ratio HR 45 Pro forma adjusted EBITDA 45 elevated LDH 45 #.#bln rbl [002] 45 procalcitonin 45 CI #.#-#.# [001] 45 EUR Mio 45 - Operating [004] 45 multivariate regression analysis 45 Mostly Cloudy Currently 45 - Non GAAP [009] 45 CFR § #.# [001] 45 RONW 45 Dany Heatley Pahlsson 45 ASUR regulated 45 LBITDA 45 serum sodium concentration 45 MCEV 45 earnings pershare 45 #.# Crores [003] 45 serum magnesium 45 Normalized Funds 45 #.#-#.# excluding 45 RUR#.# [006] 45 RVUs 45 molar ratio 45 Adjustment Expenses 45 ebita 45 IAS IFRS accounting 45 #-#.# mln [002] 45 SEK -#.# [002] 45 annualizes 45 1c HbA 1c 45 Supplementary Table 45 Consolidated OIBDA 45 unactivated equipment 45 TSE# closed 45 #.#mln rub [005] 45 JGB yield edged 45 Pro forma Adjusted EBITDA 45 Nifty PCR 45 Non GAAP adjusted EBITDA 45 SunOpta Foods 45 #.#mln [006] 45 CRE mezzanine 45 rebalanced quarterly 45 theprior 45 + - + - [009] 45 Operative mortality 45 - - Non GAAP [006] 45 MARKET TALK Saudi 45 ASHRAE Standard 45 GDAXI indexes 45 undepreciated assets 45 - - Income [031] 45 asymptomatic hyperuricemia 45 alanine aminotransferase ALT 45 FASB ASC #-# 45 totaled SEK 45 Meta analyzes 45 Tasigna prolongs 45 H1 FY# [001] 45 #.#x FY#E [002] 45 FASB Emerging 45 lifts Tussey Mountain 45 EUR -#.# -#.# [001] 45 3GPP specification 45 NTAV 45 multivariable Cox 45 Extra Ordinary Items 45 Spousal Highest Daily 45 hemoglobin Hb 45 EBIDA 45 MNOK #.# 45 Earning Per Share 45 PLAR 45 § #.#-# [007] 45 #year/# 45 DOSAGE AND ADMINISTRATION 45 dose Iluvien 45 Eligibility criteria 45 = Weighted average [026] 45 adjuvant systemic 45 NYS RN 45 Age Suitability 45 Medcath NASDAQ MDTH 45 Historical Volatility 45 SEK -# 45 FFO + GOS 45 NAIC RBC 45 approx. USD# 45 Adjusted EBITDAX 45 Levered Free Cash Flow 45 Consolidated EBITDA Margin 45 Remuneration Code 45 mln PY 45 - - [054] 45 c Calculated 45 ConAgra Foods 2Q 45 Kleros RE IV 45 interrater 45 #.#mln rub [006] 45 Tonnes mined 45 #.#bn rub [002] 45 ASC Topic 45 b Computed 45 SCOTT TRAVIS covers 45 BSE# 45 GBP #.#m [003] 45 SLHCs 45 Than Temporary Impairments 45 +#-# [019] 45 urinary albumin excretion 45 income1 45 YY =Anders Ostergaard 45 Bid increments 45 Total Leverage Ratio 45 dBFS 45 SECOND GUIDE TO 45 #.#mln rub [004] 45 Individual Annuities segment 45 -#,# #,# [004] 45 postdischarge 45 EORTC QLQ C# 45 #.#bn rub [005] 45 billion soums 45 neat farmhouses 45 excluding depreciation depletion 45 Normalised headline 45 #-# bps 45 Yearly mammograms 45 ZAR#.# [006] 45 RUDDY 'S #s 45 normalized EPS 45 bps sequentially 45 EUR#.#bn [003] 45 PMPM basis 44 jumbo adjustable loan 44 HK#.# cents [002] 44 FAS# R 44 BVPS 44 waist circumference WC 44 DiaMed acquisition 44 notes UST#Y 44 estimated GFR 44 TCE ratio 44 perinatal outcomes 44 N telopeptide 44 operating EBIDA 44 ended September# 44 PSA nadir 44 #-#.# [016] 44 ionotropic 44 intrinsic viscosity 44 Legal #.# 44 nmol L. 44 PTOI 44 EBITDA1 44 GRI Sustainability Reporting 44 FAD payout ratio 44 - Adjusted [016] 44 Billable headcount 44 Q4 F# 44 Realised Earnings 44 -# TEUR 44 Variable annuity 44 Average Equity ROAE 44 MSEK -# [002] 44 SX3P 44 hemoglobin concentrations 44 - Adjusted [003] 44 elemental calcium 44 #mmHg [002] 44 consolidated OIBDA 44 IQR 44 Invested Capital ROIC 44 EBIDTA margins 44 urinary excretion 44 YonY 44 CFR § #.# [002] 44 Reported Unaudited Condensed 44 Efficiency ratio GAAP 44 UCITS Directive 44 Instalment Warrants 44 Overnight Repurchase 44 USD#.#m USD#.# [002] 44 #,# #,# #,# [012] 44 Variable Interest Entities VIEs 44 two-year/#-year yield spread 44 Measurement Uncertainty 44 6x FY#E 44 tungsten WO3 44 catastrophe reinsurance reinstatement 44 Electro Rent NASDAQ ELRC 44 Adjusted 44 millioncompared 44 noninterest expense partially offset 44 -Elie Nadelman 44 Standards GIPS 44 CMBS collateral 44 Annual Reset 44 serum phosphorus levels 44 Invested Capital 44 #.#mln rub [001] 44 CALCRIM Nos. 44 Capital Adequacy 44 NOK#.# [006] 44 ATCF 44 OPEB expense 44 SPIAS 44 #bps yoy [001] 44 buck converters 44 Deductions depreciation 44 Expense Adjustment 44 EUR#.#B [005] 44 - Adjusted [029] 44 AFFO + GOS 44 Solvency ratio 44 unallocated corporate 44 Escorts Balanced Fund 44 DAC unlocking 44 serum lipid 44 notes UST2YR 44 Efficiency ratio equals 44 Normalized EBITDA 44 maturity YTM 44 Movado boutiques 44 Net Tangible Assets 44 addback 44 RoCE 44 Descriptive statistics 44 #,# #,# [003] 44 SEK -#.# -#.# [001] 44 GAAP Operating Margin 44 BENECOL R Spreads 44 correlation coefficients 44 e# e# [001] 44 - - Income [012] 44 #.#per [002] 44 § #.#-# [004] 44 Nasal Sprays 44 - Non GAAP [004] 44 ± SEM 44 SEK #.#M #.# 44 upholstery fabrics segment 44 Bombay Tenancy 44 Reconciling Items 44 - Adjusted [021] 44 goodwill amortization 44 Equity RoE 44 Drill composites 44 IFRSs 44 Magazine newstand price 44 #.#:# #.#:# [001] 44 deeply ingrained maladaptive 44 FIFO EBITDA 44 Randomized Controlled Trials 44 ROCE 44 HbA1C 44 - - Non GAAP [007] 44 Normalized EPS 44 assets RoA 44 Supplemental Schedules 44 month Klibor 44 sugar sweetened carbonated beverages 44 Accounting Standard AASB 44 netincome 44 Interest Coverage Ratio 44 LIST OF TABLES Table 44 HUF#.# billion [002] 44 Miscellaneous Manufacturing 44 EUR -#.# [002] 44 Time Charter Equivalent 44 free EudoraNews.com registration 44 #.#-# [005] 44 Affirms FY# 44 BMI percentiles 44 AFEP MEDEF 44 dividing noninterest expense 44 ACIP recommendations 44 Stock Upgrades Downgrades 44 higherthan 44 adopted Accounting Guideline 44 Consolidated adjusted EBITDA 44 Introductory teaser rates 44 offiscal 44 2 #/#-year CDs 44 Risk premia 44 #.#/diluted share 44 - Non GAAP [008] 44 bps qoq 44 amortization EBITA 44 KDOQI 44 -Caged Bird Sings 44 Och Ziff Operating 44 Real disposable incomes 44 HBeAg seroconversion 44 MXN# #mn 44 - Adjusted EBITDA [001] 44 Income Tax Regs 44 PLN#.# billion [002] 44 pro forma MADS 44 mainline CASM 44 MutualFirst Announces 44 Id. § 44 EBITA margin 44 ShengdaTech NASDAQ SDTH 44 equity excluding AOCI 44 #Y yield 44 LTCH PPS 44 Sees FY# adj EPS 44 #.#-#.# bln [002] 44 #.# bln sfr [002] 44 excluding divestments 44 DPAC amortization 44 Fixed annuity 44 PREHEAT oven 44 Operating netbacks 44 Additions Accrual Basis 44 expiratory flow 44 provisioning norms 44 Years Duration Corporate 44 Sees Q# 43 diagnosing ADHD 43 Brillstein Entertainment credits 43 EPS Excl 43 EBDITA 43 WOMAC pain 43 Adjusted Operating Expenses 43 Manat exchange 43 warfarin dosage 43 #.# crores [001] 43 Nonoperating Income Expense 43 #.#-# b [001] 43 FSP APB #-# 43 free BaldwinCity.com registration 43 -Lee Seung chul 43 #bps yoy [002] 43 CORE OM 43 creatinine ratio 43 serum folate 43 Avoid caffeine 43 - - Nforecaddie 43 V# max 43 TTM gross 43 aminotransferase levels 43 ISK #.#bn EUR 43 interquartile range 43 Dec Eurodollars 43 interannual 43 urinary albumin 43 FNCL 43 CFR pt 43 #.#B [003] 43 tax equivalized 43 Treasury notes UST#Y 43 Rs5 #cr 43 Industrial CFOA 43 normal LLN 43 ratios 43 Non GAAP adjustments 43 XLP SPY Relative Strength 43 multivariable adjusted 43 nine monthsended 43 CFNAI 43 ZDP Shares 43 A#.# #.#c 43 BPH Symptom Score 43 mL sec 43 Core noninterest expense 43 Lifts FY# 43 FY#E ABV 43 accretion DD & 43 9bp 43 #.# bln dkr [002] 43 bonds UST#Y 43 Conversion Factor 43 Gaap 43 Maintenance Capital Expenditures 43 Items impacting comparability 43 Pretax 43 purposes Torchmark defers 43 TEUR -# 43 #,# AZN 43 -#,# -#,# [009] 43 inter segmental 43 CDO financings 43 GBP#.#B [001] 43 Total Capitalization Ratio 43 #.#-#.# bln usd [003] 43 reconciles GAAP 43 Dietary Reference Intakes 43 KIID 43 unallocated expenses 43 Adjusted Diluted EPS 43 EPADS 43 #.#mln rbl [001] 43 Bulk density 43 - - Nesignandsight newsletter 43 Emissions Trading Directive 43 +# bp [002] 43 ratio ICER 43 nonoperating expense 43 SILO LILO charges 43 futures SPc1 rose 43 mercury shark swordfish 43 cystoscopic 43 Final Appraisal Determination 43 ICH guidelines 43 Fully diluted earnings 43 #.#x #.#x [003] 43 adopting SFAS #R 43 #.#c #.#c [006] 43 #.#/BOE [001] 43 client reimbursables 43 HB# Provides [001] 43 GBP#.#b 43 serum CRP 43 #,# #,# #,# #,# [004] 43 Unitholder distributions 43 invoiced shipment 43 #.#-#.# pct [001] 43 Non GAAP 43 - - [015] 43 reclass 43 Equity Investees 43 EBITDARM 43 FSP FAS #-# 43 - - Net [047] 43 NIHSS score 43 Profit Margin 43 Loss severities 43 - - Adjusted [005] 43 Pro Forma EBITDA 43 FY#e 43 - - Non GAAPHawai'i Paroling Authority 43 Recent Accounting Pronouncements 43 #mg/dl 43 IPSAS 43 Reclassifications 43 systolic diastolic 43 #bp QoQ 43 intraclass correlation coefficients 43 dollar denominated Libor 43 IAS IFRS 43 Supervalu 3Q 43 Revised Loan Amount 43 ninemonths 43 Discontinued Lines 43 reweighted 43 loss carrybacks 43 Astec Industries NASDAQ ASTE 43 Significant Items 43 Bilgena Read Terms 43 CFR #.#b 43 Eurosystem collateral 43 GRI Guidelines 43 standardized distributable cash 43 Mr. Nemenoff describes 43 dissuasive effect 43 Sees FY# EPS 43 OSIs 43 Nonfat dry milk 43 systolic blood pressures 43 actuarially equivalent 43 comparably rated 43 prevalences 43 SBLIC 43 #.#-# mln [001] 43 acute febrile 43 CROCS NASDAQ CROX 43 Womacks Adjusted EBITDA 43 SFAS# R 43 Och Ziff Funds 43 Matches Consensus 43 omega fats 43 value OLTV ratio 43 Standards Codification ASC 43 A1c levels 43 nondeductible expenses 43 noninterest expense totaled 43 - Loss [026] 43 factor WARF 43 aged ≥ 43 Council Directive #/#/EEC 43 fiscal# 43 Hormel 3Q 43 Core PCE inflation 43 CICA Handbook section 43 SORP 43 LIFO inventory 43 highest tertile 43 GBP'# 43 Sofix 43 PUFA intake 43 -dnj.com 43 Assets ROA 43 Compensation Expense 43 INDUSTRY DEFINITION Industry 43 PRIZES Prize s 43 adjusted 43 -RDPP 43 Inc. Nasdaq CRWN 43 - - [005] 43 currency remeasurement 43 Industry Classification Benchmark 43 = NetSao Pedro 43 similarly captioned 43 symptom exacerbation 43 Sees FY 43 YoverY 43 per dilutedshare 43 CIM Best Practices 43 regression coefficient 43 Delinquency Bulletin 43 #:# #:# [001] 43 capitalizable 43 EBIT 43 + Pd g t 43 LS BMD 43 - - [092] 43 OREO write downs 43 Adjusted diluted 43 FASB #R 43 Accounting Guideline 43 dietary modification 43 amortization OIBDA 43 inhibitory concentrations 43 postretirement obligations 43 OFZ curve 43 First BanCorp Announces 43 -#,# -#,# [011] 43 Taxable Equivalent Basis 43 apo B 43 CFR § § 43 dose inhaled corticosteroid 43 mso font pitch 43 ppt Operating 43 Installers Drug 43 Evid. Code § § 43 Crisil Composite 43 serum ALT 43 oxyhemoglobin 43 NJSA #:#-# [004] 43 cytologic 43 Standard msg 43 FY#E EV EBITDA 43 NCEP ATP III 43 #/#/EEC [002] 43 glutamate glutamine 43 LIFO accounting 43 Q4 FY'# 43 endometrial thickness 43 symptomatic intracerebral hemorrhage 43 mEUR 43 beta coefficient 43 psychotherapeutic interventions 43 NOTES Applicable 43 Unfunded liabilities 43 Segment EBIT 43 Q#-Q#/# [002] 43 1mg/kg 43 NIM compression 43 serum aminotransferase levels 43 SmPC 43 oxygen saturations 43 nondeductible portion 43 DAC offsets 43 EDITDA 43 Currency Translation 43 FY#E FY#E 43 resuscitated cardiac arrest 43 Loss Ratios 43 Marketwide rollover 43 voltage derating 42 Maintain BUY 42 adjusted ebitda 42 - Net [011] 42 FDIC indemnification 42 Percentage Percentage 42 -Josephine Marcotty 42 Efficiency Ratio 42 Industry Classification Benchmark ICB 42 AUCs 42 Items excluded 42 sUA levels 42 = Diluted [019] 42 GRI G3 42 Various Types 42 ANCOVA 42 mean serum phosphorus 42 EITF #-#-# 42 HDFC Prudence Fund 42 Items Affecting Comparability 42 Chemicals Segment 42 Performance Standards GIPS 42 variograms 42 - Adjusted [017] 42 - Adjusted [006] 42 Sensitivity Analysis 42 benchmark PLR 42 CHF#.#m [001] 42 self directedness 42 stock basedcompensation 42 equity method investees 42 Guidelines WCAG 42 Dietary guidelines 42 reports Q3 adj 42 Burgl Unoccupied Conveyance Unarmed 42 free ShawneeDispatch.com registration 42 TFG CLO 42 d Calculated 42 ROFE 42 Competent Adviser Status 42 9bps 42 CRAR 42 somatoform disorders